loader
Please Wait
Applying Filters...

Evonik Evonik

X

Technical details about APG-1387, learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
1. Also known as: Apg-1387, 1570231-89-8, E53vn70k2x, Apg1387, (s,5s,5's,8s,8's,10ar,10a'r)-3,3'-(1,3-phenylenedisulfonyl)bis(n-benzhydryl-5-((s)-2-(methylamino)propanamido)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide), Unii-e53vn70k2x
Molecular Formula
C60H72N10O10S2
Molecular Weight
1157.4  g/mol
InChI Key
AKLBERUGKZNEJY-RTEPGWBGSA-N
FDA UNII
E53VN70K2X

IAP Inhibitor APG-1387 is a small molecule, second mitochondria-derived activator of caspases (SMAC)-mimetic targeting inhibitor of apoptosis proteins (IAPs) with potential apoptosis-inducing and antineoplastic activities. Upon administration, IAP inhibitor APG-1387 selectively binds to and inhibits the activity of IAPs including X chromosome-linked IAP (XIAP) and cellular IAPs 1 (c-IAP1) and 2 (c-IAP2). This may restore and promote the induction of apoptosis through apoptotic signaling pathways and enhance proteasomal degradation of IAPs. Additionally, APG-1387 may work synergistically with cytotoxic drugs to overcome tumor cell resistance to apoptosis. IAPs are overexpressed by many cancer cell types, suppressing apoptosis by binding and inhibiting active caspases-3, -7 and -9 via their BIR (baculoviral lAP repeat) domains.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(5S,8S,10aR)-3-[3-[[(5S,8S,10aR)-8-(benzhydrylcarbamoyl)-5-[[(2S)-2-(methylamino)propanoyl]amino]-6-oxo-1,2,4,5,8,9,10,10a-octahydropyrrolo[1,2-a][1,5]diazocin-3-yl]sulfonyl]phenyl]sulfonyl-N-benzhydryl-5-[[(2S)-2-(methylamino)propanoyl]amino]-6-oxo-1,2,4,5,8,9,10,10a-octahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide
2.1.2 InChI
InChI=1S/C60H72N10O10S2/c1-39(61-3)55(71)63-49-37-67(34-32-45-28-30-51(69(45)59(49)75)57(73)65-53(41-18-9-5-10-19-41)42-20-11-6-12-21-42)81(77,78)47-26-17-27-48(36-47)82(79,80)68-35-33-46-29-31-52(70(46)60(76)50(38-68)64-56(72)40(2)62-4)58(74)66-54(43-22-13-7-14-23-43)44-24-15-8-16-25-44/h5-27,36,39-40,45-46,49-54,61-62H,28-35,37-38H2,1-4H3,(H,63,71)(H,64,72)(H,65,73)(H,66,74)/t39-,40-,45+,46+,49-,50-,51-,52-/m0/s1
2.1.3 InChI Key
AKLBERUGKZNEJY-RTEPGWBGSA-N
2.1.4 Canonical SMILES
CC(C(=O)NC1CN(CCC2CCC(N2C1=O)C(=O)NC(C3=CC=CC=C3)C4=CC=CC=C4)S(=O)(=O)C5=CC(=CC=C5)S(=O)(=O)N6CCC7CCC(N7C(=O)C(C6)NC(=O)C(C)NC)C(=O)NC(C8=CC=CC=C8)C9=CC=CC=C9)NC
2.1.5 Isomeric SMILES
C[C@@H](C(=O)N[C@H]1CN(CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(C3=CC=CC=C3)C4=CC=CC=C4)S(=O)(=O)C5=CC(=CC=C5)S(=O)(=O)N6CC[C@H]7CC[C@H](N7C(=O)[C@H](C6)NC(=O)[C@H](C)NC)C(=O)NC(C8=CC=CC=C8)C9=CC=CC=C9)NC
2.2 Other Identifiers
2.2.1 UNII
E53VN70K2X
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Apg-1387

2.3.2 Depositor-Supplied Synonyms

1. Apg-1387

2. 1570231-89-8

3. E53vn70k2x

4. Apg1387

5. (s,5s,5's,8s,8's,10ar,10a'r)-3,3'-(1,3-phenylenedisulfonyl)bis(n-benzhydryl-5-((s)-2-(methylamino)propanamido)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide)

6. Unii-e53vn70k2x

7. Schembl15490706

8. Apg-1387 [who-dd]

9. A][1,5]diazocine-8-carboxamide)

10. Ex-a5180

11. Apg-1387 (smac Mimetic)

12. Nsc834197

13. Nsc-834197

14. Sm-1387

15. Hy-125593

16. Cs-0092417

17. Phenylenedisulfonyl)bis(n-benzhydryl-5-((s)-2-

18. (methylamino)propanamido)-6-oxodecahydropyrrolo[1,2-

19. (5s,5's,8s,8's,10ar,10a'r)-3,3'-(1,3-

2.4 Create Date
2014-03-31
3 Chemical and Physical Properties
Molecular Weight 1157.4 g/mol
Molecular Formula C60H72N10O10S2
XLogP34.5
Hydrogen Bond Donor Count6
Hydrogen Bond Acceptor Count14
Rotatable Bond Count18
Exact Mass1156.48743088 g/mol
Monoisotopic Mass1156.48743088 g/mol
Topological Polar Surface Area273 Ų
Heavy Atom Count82
Formal Charge0
Complexity2240
Isotope Atom Count0
Defined Atom Stereocenter Count8
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Post Enquiry
POST ENQUIRY